These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 31746070)

  • 21. Zika virus disease-associated Guillain-Barré syndrome-Barranquilla, Colombia 2015-2016.
    Salinas JL; Walteros DM; Styczynski A; Garzón F; Quijada H; Bravo E; Chaparro P; Madero J; Acosta-Reyes J; Ledermann J; Arteta Z; Borland E; Burns P; Gonzalez M; Powers AM; Mercado M; Solano A; Sejvar JJ; Ospina ML
    J Neurol Sci; 2017 Oct; 381():272-277. PubMed ID: 28991697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zika Virus Infection in the Elderly: Possible Relationship with Guillain-Barré Syndrome.
    Savino W; Messias CV; Mendes-da-Cruz DA; Passos P; Ferreira AC; Nascimento OJ
    Gerontology; 2017; 63(3):210-215. PubMed ID: 28002820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real-Time Assessment of Health-Care Requirements During the Zika Virus Epidemic in Martinique.
    Andronico A; Dorléans F; Fergé JL; Salje H; Ghawché F; Signate A; Daudens-Vaysse E; Baudouin L; Dub T; Aubry M; Cao-Lormeau VM; Ledrans M; Noel H; Mallet HP; Fontanet A; Cabié A; Cauchemez S
    Am J Epidemiol; 2017 Nov; 186(10):1194-1203. PubMed ID: 28200111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Zika virus infection and Guillain-Barré syndrome: a review focused on clinical and electrophysiological subtypes.
    Uncini A; Shahrizaila N; Kuwabara S
    J Neurol Neurosurg Psychiatry; 2017 Mar; 88(3):266-271. PubMed ID: 27799296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Increased rates of Guillain-Barré syndrome associated with Zika virus outbreak in the Salvador metropolitan area, Brazil.
    Styczynski AR; Malta JMAS; Krow-Lucal ER; Percio J; Nóbrega ME; Vargas A; Lanzieri TM; Leite PL; Staples JE; Fischer MX; Powers AM; Chang GJ; Burns PL; Borland EM; Ledermann JP; Mossel EC; Schonberger LB; Belay EB; Salinas JL; Badaro RD; Sejvar JJ; Coelho GE
    PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005869. PubMed ID: 28854206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Zika virus outbreak in New Caledonia and Guillain-Barré syndrome: a case-control study.
    Simon O; Acket B; Forfait C; Girault D; Gourinat AC; Millon P; Daures M; Vanhomwegen J; Billot S; Biron A; Hoinard D; Descloux E; Guyon D; Manuguerra JC; Laumond S; Molko N; Dupont-Rouzeyrol M
    J Neurovirol; 2018 Jun; 24(3):362-368. PubMed ID: 29594985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence of Guillain-Barré syndrome among Zika virus infected cases: a systematic review and meta-analysis.
    Barbi L; Coelho AVC; Alencar LCA; Crovella S
    Braz J Infect Dis; 2018; 22(2):137-141. PubMed ID: 29545017
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Guillain-Barré syndrome and Zika virus outbreaks.
    Nascimento OJM; da Silva IRF
    Curr Opin Neurol; 2017 Oct; 30(5):500-507. PubMed ID: 28617719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guillain-Barré syndrome outbreak in Tapachula temporally associated with the Zika virus introduction in Southern Mexico.
    Rodríguez de la Rosa RP; Cano-Torres JO; Rosales S; Kleinert AP; Gómez A; George F; George J; Piedad García M; Nájera-Cancino G; Guerra-de-Blas PDC; Belaunzarán-Zamudio PF; Beigel J; Ruiz-Palacios GM;
    Epidemiol Infect; 2022 Oct; 150():e181. PubMed ID: 36384981
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of adult patients with Guillain-Barré syndrome during the arboviral infection outbreaks in Honduras.
    Sánchez OA; Portillo KM; Reyes-Garcia SZ; England JD; Medina MT
    J Neurol Sci; 2021 Aug; 427():117551. PubMed ID: 34171744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guillain-Barré Syndrome During Ongoing Zika Virus Transmission - Puerto Rico, January 1-July 31, 2016.
    Dirlikov E; Major CG; Mayshack M; Medina N; Matos D; Ryff KR; Torres-Aponte J; Alkis R; Munoz-Jordan J; Colon-Sanchez C; Salinas JL; Pastula DM; Garcia M; Segarra MO; Malave G; Thomas DL; Rodríguez-Vega GM; Luciano CA; Sejvar J; Sharp TM; Rivera-Garcia B
    MMWR Morb Mortal Wkly Rep; 2016 Sep; 65(34):910-4. PubMed ID: 27584942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An assessment of public health surveillance of Zika virus infection and potentially associated outcomes in Latin America.
    Bautista LE; Herrera VM
    BMC Public Health; 2018 May; 18(1):656. PubMed ID: 29793453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neurological Implications of Zika Virus Infection in Adults.
    Muñoz LS; Parra B; Pardo CA;
    J Infect Dis; 2017 Dec; 216(suppl_10):S897-S905. PubMed ID: 29267923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Time Lags between Exanthematous Illness Attributed to Zika Virus, Guillain-Barré Syndrome, and Microcephaly, Salvador, Brazil.
    Paploski IA; Prates AP; Cardoso CW; Kikuti M; Silva MM; Waller LA; Reis MG; Kitron U; Ribeiro GS
    Emerg Infect Dis; 2016 Aug; 22(8):1438-44. PubMed ID: 27144515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zika Virus infection and Guillain-Barré syndrome in Northeastern Mexico: A case-control study.
    Gongora-Rivera F; Grijalva I; Infante-Valenzuela A; Cámara-Lemarroy C; Garza-González E; Paredes-Cruz M; Grajales-Muñiz C; Guerrero-Cantera J; Vargas-Ramos I; Soares J; Abrams JY; Styczynski AR; Camacho-Ortiz A; Villarino ME; Belay ED; Schonberger LB; Sejvar JJ;
    PLoS One; 2020; 15(3):e0230132. PubMed ID: 32214354
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increase in Guillain-Barré syndrome hospitalizations in Brazil: an ecological study.
    Malta JMAS; Ramalho WM
    Epidemiol Serv Saude; 2020; 29(4):e2020056. PubMed ID: 32844917
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Guillain-Barré syndrome risk among individuals infected with Zika virus: a multi-country assessment.
    Mier-Y-Teran-Romero L; Delorey MJ; Sejvar JJ; Johansson MA
    BMC Med; 2018 May; 16(1):67. PubMed ID: 29759069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Olfactory outcomes in Zika virus-associated Guillain-Barré syndrome.
    Lazarini F; Lannuzel A; Cabié A; Michel V; Madec Y; Chaumont H; Calmont I; Favrat M; Montagutelli X; Roze E; Lledo PM;
    Eur J Neurol; 2022 Sep; 29(9):2823-2831. PubMed ID: 35699338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study.
    Cao-Lormeau VM; Blake A; Mons S; Lastère S; Roche C; Vanhomwegen J; Dub T; Baudouin L; Teissier A; Larre P; Vial AL; Decam C; Choumet V; Halstead SK; Willison HJ; Musset L; Manuguerra JC; Despres P; Fournier E; Mallet HP; Musso D; Fontanet A; Neil J; Ghawché F
    Lancet; 2016 Apr; 387(10027):1531-1539. PubMed ID: 26948433
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of Guillain-Barré Syndrome in the integrated development region of the Federal District and Surrounding Areas (RIDE), Brazil, between 2017 and 2019.
    Oliveira AFM; Silva AWMD; Manga Aridjae U; Bastos MM; Wachira VK; Gallo LG
    Acta Trop; 2022 May; 229():106366. PubMed ID: 35150642
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.